* is taking high-dose hydroxychloroquine or chloroquine. * is taking pimozide or strong or moderate cyp3a4 inhibitors. * is currently receiving treatment with products intended to modify immune response to covid-19 (exception: dexamethasone, methylprednisolone, or equivalent are allowed), chemotherapy or on hemodialysis or peritoneal dialysis. * has known hypersensitivity to any components of aprepitant injectable emulsion. * has evidence of ards. * is being treated with oxygen delivered by high-flow nasal cannula nonrebreather mask, noninvasive positive pressure ventilation, or ecmo. * has multiple organ failure. * has current confirmed influenza a or b infection, or a a history of organ or hematologic transplant, hiv, or active hepatitis b or hepatitis c infection.

* is taking high-dose hydroxychloroquine or chloroquine. * is taking pimozide or strong or moderate cyp3a4 inhibitors. * is currently receiving treatment with products intended to modify immune response to covid-19 (exception: dexamethasone, methylprednisolone, or equivalent are allowed), chemotherapy or on hemodialysis or peritoneal dialysis. * has known hypersensitivity to any components of aprepitant injectable emulsion. * has evidence of ards. * is being treated with oxygen delivered by high-flow nasal cannula nonrebreather mask, noninvasive positive pressure ventilation, or ecmo. * has multiple organ failure. * has current confirmed influenza a or b infection, or a a history of organ or hematologic transplant, hiv, or active hepatitis b or hepatitis c infection.

- is taking high-dose hydroxychloroquine or chloroquine. - is taking pimozide or strong or moderate cyp3a4 inhibitors. - is currently receiving treatment with products intended to modify immune response to covid-19 (exception: dexamethasone, methylprednisolone, or equivalent are allowed), chemotherapy or on hemodialysis or peritoneal dialysis. - has known hypersensitivity to any components of aprepitant injectable emulsion. - has evidence of ards. - is being treated with oxygen delivered by high-flow nasal cannula nonrebreather mask, noninvasive positive pressure ventilation, or ecmo. - has multiple organ failure. - has current confirmed influenza a or b infection, or a a history of organ or hematologic transplant, hiv, or active hepatitis b or hepatitis c infection.

- is taking high-dose hydroxychloroquine or chloroquine. - is taking pimozide or strong or moderate cyp3a4 inhibitors. - is currently receiving treatment with products intended to modify immune response to covid-19 (exception: dexamethasone, methylprednisolone, or equivalent are allowed), chemotherapy or on hemodialysis or peritoneal dialysis. - has known hypersensitivity to any components of aprepitant injectable emulsion. - has evidence of ards. - is being treated with oxygen delivered by high-flow nasal cannula nonrebreather mask, noninvasive positive pressure ventilation, or ecmo. - has multiple organ failure. - has current confirmed influenza a or b infection, or a a history of organ or hematologic transplant, hiv, or active hepatitis b or hepatitis c infection.

- is taking high-dose hydroxychloroquine or chloroquine. - is taking pimozide or strong or moderate cyp3a4 inhibitors. - is currently receiving treatment with products intended to modify immune resp)onse to covid-19 (exception: dexamethasone, methylprednisolone, or equivalent are allowed, chemotherapy or on hemodialysis or peritoneal dialysis. - has known hypersensitivity to any components of aprepitant injectable emulsion. - has evidence of ards. - is being treated with oxygen delivered by high-flow nasal cannula nonrebreather mask, noninvasive positive pressure ventilation, or ecmo. - has multiple organ failure. - has current confirmed influenza a or b infection, or a a history of organ or hematologic transplant, hiv, or active hepatitis b or hepatitis c infection.

- is taking high-dose hydroxychloroquine or chloroquine. - is taking pimozide or strong or moderate cyp3a4 inhibitors. - is currently receiving treatment with products intended to modify immune resp)onse to covid-19 (exception: dexamethasone, methylprednisolone, or equivalent are allowed, chemotherapy or on hemodialysis or peritoneal dialysis. - has known hypersensitivity to any components of aprepitant injectable emulsion. - has evidence of ards. - is being treated with oxygen delivered by high-flow nasal cannula nonrebreather mask, noninvasive positive pressure ventilation, or ecmo. - has multiple organ failure. - has current confirmed influenza a or b infection, or a a history of organ or hematologic transplant, hiv, or active hepatitis b or hepatitis c infection.